CareNu Subsidiary SECUR Receives HMO License
SECUR's Medicare Advantage special needs plan will enable CareNu to better serve individuals with advanced chronic illness
"CareNu's SECUR embodies our mission to be a lifeline for individuals battling complex chronic illness, offering a level of care and support unparalleled in the industry," said
"Since its founding, CareNu has driven the evolution of chronic care illness management in the nation, achieving groundbreaking improvements in health outcomes," said
The new plan will emulate CareNu's other successful programs, which coordinate chronic illness care for over 5,000 people. Through ASSURITY DCE, the organization has revolutionized care for more than 2,000 patients. From 2021 to 2023, the program saw a 52-percent reduction in emergency room visits and a 61-percent reduction in hospitalizations, as a result of its commitment to comprehensive, preventative care.
To learn more about SECUR, visit www.securhealthplan.com.
About CareNu
CareNu is a data-forward healthcare organization using predictive analytics to revolutionize care for the medically vulnerable and their families. CareNu is at the forefront of a new healthcare approach in America by leveraging data and resources to optimize the patient experience and care delivery model. The organization also operates several at-home primary care entities, a health plan and numerous global risk initiatives. It operates on a value-based care model and encompasses the entire health ecosystem for chronic illness care. CareNu is a subsidiary of Chapters Health System, a collective of advanced illness companies including 10 hospices, behavioral health services, PACE centers and a pharmacy company. CareNu embraces innovation to transform the patient-family experience. To discover the future of healthcare, visit www.carenu.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/carenu-subsidiary-secur-receives-hmo-license-302126702.html
SOURCE CareNu
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Technological Breakthrough丨Niutech's Titanium-Iron Tailings Reduction and Enrichment Technology and Equipment Boost Global Strategic Mineral Resource Recovery
- Alphinat Announces a Loss of $(44,521) for Quarter Ended May 31, 2026
- ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share